| Name | Marmet Center |
|---|---|
| Location | One Sutphin Drive, Marmet, West Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 90 |
| Occupancy Rate | 91% |
| Medicare ID (CCN) | 515146 |
| Legal Business Name | 1 Sutphin Drive Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1194728097 |
| Organization Name | MARMET HEALTH CARE CENTER |
| Address | 1 Sutphin Dr, Marmet, WV 25315 |
| Phone Number | 304-949-1580 |
News Archive
Weight Watchers has helped millions of American adults successfully lose weight and now results from a pilot, family-focused Weight Watchers approach designed to support parents shows potential for success in reducing excess weight in children, according to a study presented at the Experimental Biology Annual Meeting, Anaheim, Calif., April 27, 2010.
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
As a science-based institution, WHO is always striving to be at the forefront of scientific progress and its potential to improve health for all.
According to the Australian Institute of Health and Welfare (AIHW) while the number of medical practitioners rose between 2002 and 2006, the supply of primary care doctors fell.
› Verified 6 days ago
| NPI Number | 1538343710 |
| Organization Name | 1 SUTPHIN DRIVE OPERATIONS LLC |
| Doing Business As | MARMET CENTER |
| Address | 1 Sutphin Dr, Marmet, WV 25315 |
| Phone Number | 304-949-2000 |
News Archive
Weight Watchers has helped millions of American adults successfully lose weight and now results from a pilot, family-focused Weight Watchers approach designed to support parents shows potential for success in reducing excess weight in children, according to a study presented at the Experimental Biology Annual Meeting, Anaheim, Calif., April 27, 2010.
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
As a science-based institution, WHO is always striving to be at the forefront of scientific progress and its potential to improve health for all.
According to the Australian Institute of Health and Welfare (AIHW) while the number of medical practitioners rose between 2002 and 2006, the supply of primary care doctors fell.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Weight Watchers has helped millions of American adults successfully lose weight and now results from a pilot, family-focused Weight Watchers approach designed to support parents shows potential for success in reducing excess weight in children, according to a study presented at the Experimental Biology Annual Meeting, Anaheim, Calif., April 27, 2010.
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
As a science-based institution, WHO is always striving to be at the forefront of scientific progress and its potential to improve health for all.
According to the Australian Institute of Health and Welfare (AIHW) while the number of medical practitioners rose between 2002 and 2006, the supply of primary care doctors fell.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $41022 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.8 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 14.06 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 38.81 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.31 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.37 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.76 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.17 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 81.72 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.42 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 44.39 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.9 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 37.09 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.48 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.56 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 76.99 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 61.5 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 52.91 | 82.93 |
News Archive
Weight Watchers has helped millions of American adults successfully lose weight and now results from a pilot, family-focused Weight Watchers approach designed to support parents shows potential for success in reducing excess weight in children, according to a study presented at the Experimental Biology Annual Meeting, Anaheim, Calif., April 27, 2010.
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
As a science-based institution, WHO is always striving to be at the forefront of scientific progress and its potential to improve health for all.
According to the Australian Institute of Health and Welfare (AIHW) while the number of medical practitioners rose between 2002 and 2006, the supply of primary care doctors fell.
› Verified 6 days ago